Siarez, Danilo, N/A. A.
HRN: 23-16-31 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/31/2023
07/31/2023
IV
4.5gms
LD
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes